Zantac Recalled Over Concern of Contamination with Carcinogen
In an important health alert, media in US and abroad have reported on public about the recall of some brands of Ranitidine, the anti-acid/heartburn medicine commonly sold under the generic name Zantac.
MedScape reported on September 24th that pharmaceutical company Sandoz Inc. has “voluntarily recalled all generic Zantac” in the United States because some batches of the medicine were found to be contaminated with N-nitrosodimethylamine (NDMA), which is a carcinogen (cancer-causing substance).
On Wednesday, September 25th, Global News reported that four more companies have recalled Zantac over the same concern of NDMA contamination. These companies are: Apotex Inc, Pro Doc Limitée, Sanis Health Inc, and Sivem Pharmaceuticals ULC. The story says that Sandoz had already recalled the drug in Canada and other countries.